You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Monday, Zingernation! Microstrategy is a Buy after it topped up its Bitcoin stack once again, analysts say. But Canaccord lowered its price target: here’s the new one.

Today, we look at which crypto sector could benefit from the Fed cutting rates, which GOP official Polymarket traders are betting on to endorse Harris and more.

Plus, the World Championship of Trading is kicking off! Get ready for the ultimate trading showdown for your chance to win cold hard cash!

Read the complete details in Contest Instructions

MARKET SNAPSHOT

TOP STORY

With Fed Rate Cuts Imminent, Here's Which Crypto Sector Could Benefit The Most, According To Bernstein

Wednesday is D-Day.

The Fed will finally start cutting rates. Whether we get 25 or 50 basis points is still to be determined but either way, crypto could benefit.

And one sector in particular could see a revival thanks to lower interest rates, according to Bernstein analysts.

Which one?

Read the full scoop here.

TOGETHER WITH TRADE ZERO

$30,000+ On The Line … World Championship Of Trading – 100% FREE to Start Trading Today!

The World Championship of Trading is kicking off! Get ready for the ultimate trading showdown for your chance to win cold hard cash!

Take home the gold and you could win:

• 💰 Up to $30,000 in USD

• 🏛️ An exclusive tour of the New York Stock Exchange

• 🫰 A lifetime subscription to Benzinga Pro

• 🐐 Lifetime bragging rights as the trading GOAT

The best part? It’s 100% free. No fee. No gimmicks. Trade virtual money. Win real cash!

Don’t wait, the competition is live! Lucky for you, the sign-up window is still open, but not for long! Click here for more information.

Read the complete details in Contest Instructions

QUICK N DIRTY

Contrarian takes are a dime a dozen in crypto. But one trader really shared a contrarian take by backing the TRUMP token after it’s down over 90% from its ATH.

Microstrategy remains a ‘Buy’ according to analysts at Canaccord. But they also lowered their price target - here’s by how much.

Dogecoin will be one the top memecoin narratives in 2025, according to the ‘Dogecoin millionaire.’ But his main winning narrative is another one.

FINTECH FOCUS

Anthony Scaramucci: 'More GOP Officials Will Start To Denounce Trump' — Senator Mitt Romney May Be One Of Them, Polymarket Traders Think

Anthony Scaramucci thinks more GOP officials will break ranks and disavow their Presidential candidate.

And it just so happens that Polymarket has a market on whether Mitt Romney will endorse Kamala Harris.

The same Romney that has referred to Trump as a “failure of a character.”

The chances a Harris endorsement happens?

Read the full scoop here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.